ProfileGDS5822 / ILMN_2749717
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 81% 83% 78% 81% 83% 73% 88% 76% 81% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1155.281
GSM1276600PDAC Late Ablation Control 2218.783
GSM1276601PDAC Late Ablation Control 3153.978
GSM1276602PDAC Late Ablation 1158.981
GSM1276603PDAC Late Ablation 2214.383
GSM1276604PDAC Late Ablation 376.673
GSM1303940PDAC Late Ablation_anti-CTLA4 1350.688
GSM1303941PDAC Late Ablation_anti-CTLA4 2122.476
GSM1303942PDAC Late Ablation_anti-CTLA4 3198.481